Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;128(1):88-101.
doi: 10.1111/jam.14443. Epub 2019 Nov 19.

Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp

Pengfei She  1 , Yiqing Liu  1 , Yangxia Wang  2 , Fang Tan  1 , Zhen Luo  1 , Yong Wu  1
Affiliations

Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp

Pengfei She et al. J Appl Microbiol. 2020 Jan.

Abstract

Aims: Staphylococcus aureus (a bacterial pathogen) and Candida sp. (opportunistic fungi) are two clinically relevant biofilm-forming microbes responsible for a majority of community- and nosocomial-acquired infections. Dual species biofilm formation between S. aureus and Candida sp. extremely enhances the antimicrobial resistance of the micro-organisms and is difficult to treat with antibiotic therapy. Hence, it is crucial to explore new antimicrobial agents. Auranofin (AF) is a mixed ligand gold compound and has recently been repurposed as an antibacterial and antifungal agent. However, the effects of AF against dual species biofilm have remained largely untested.

Methods and results: In the present study, by constructing biofilms on microplates and urinary catheter surfaces, AF showed strong planktonic cells and biofilm inhibitory effects against mono- and dual culture models of S. aureus and Candida albicans but only exhibited moderate antibiofilm effects on Candida parapsilosis. Auranofin could be synergistic with subminimal inhibitory concentrations of amphotericin B against S. aureus + C. albicans/C. parapsilosis dual biofilms. Auranofin also showed effective antimicrobial effects on vancomycin-resistant strains. However, the antimicrobial effects of AF were decreased in the presence of heat-inactivated foetal bovine serum.

Conclusions: In summary, AF could effectively inhibit S. aureus and C. albicans mono- and dual biofilm formation in vitro.

Significance and impact of the study: Coexistence between Staphylococcus aureus and Candida sp. in dual biofilms leads to increased resistance to some conventionally used antimicrobials, indicating a need for alternative treatments. This study demonstrates the potential for the Au-containing compound AF in the treatment of dual biofilm infections and encourages further investigation of this treatment for clinical use.

Keywords: Candida albicans; Candida parapsilosis; Staphylococcus aureus; auranofin; polymicrobial biofilm; urine catheter.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aguinagalde, L., Díez-Martínez, R., Yuste, J., Royo, I., Gil, C., Lasa, Í., Martín-Fontecha, M., Marín-Ramos, N.I. et al. (2015) Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections. J Antimicrob Chemother 70, 2608-2617.
    1. Cassetta, M.I., Marzo, T., Fallani, S., Novelli, A. and Messori, L. (2014) Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections. Biometals 27, 787-791.
    1. Choudhary, G.S., Yao, X., Wang, J., Peng, B., Bader, R.A. and Ren, D. (2015) Human granulocyte macrophage colony-stimulating factor enhances antibiotic susceptibility of Pseudomonas aeruginosa persister cells. Sci Rep 5, 17315.
    1. CLSI (Clinical and Laboratory Standards Institute) (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: 4th Informational Supplement. CLSI document M27-A3. Wayne, PA: CLSI.
    1. CLSI (Clinical and Laboratory Standards Institute) (2015) Performance Standards for Antimicrobial Susceptibility Testing. 23th Informational Supplement. CLSI document, M100-S25. Wayne, PA: CLSI.

MeSH terms